Our Phage Picks for April 2025

Issue 307 | April 18, 2025
11 min read
Capsid and Tail

It’s Phage Picks time! This week’s theme is bread and butter — two picks from Jess about methods papers that should be staples of any phage lab: her favourite phage-making paper, and an (aspirational) phage quantification paper she really wants to implement (hopefully soon). Plus a bonus pick from Jan on optogenetics — what is it, and why is he obsessed with it?

Urgent April 14, 2025

Urgent need for Clostridium septicum phages for a patient in Canada

Phage Therapy Osteomyelitis

We are urgently seeking Clostridium septicum phages (or any Clostridium-specific phages) for a patient with osteomyelitis in Canada. If you can help, please reach out!

Ways to help at this stage:

  • By sending your phages (or lysins!) for testing on the patient’s strains
  • By receiving the patient’s strain and testing your phages
  • By helping spread the word about this request
  • By providing us with names/email addresses of labs you think we should contact

Please email [email protected] if you can help in any way, or if you would like further details/clarification.

Let’s make a difference,
Phage Directory

What’s New

Jerry Nick (National Jewish Health) and colleagues published a new paper on trial design for phage therapy against M. abscessus in cystic fibrosis, showing a standardized protocol to assess efficacy and safety of phage treatment in refractory infections.

Clinical trial designPhage therapy

Jeremy Barr (Monash University) published a new perspective on T-series phages as reductionist models, discussing how these phages have shaped the field of microbiology and continue to be important research tools.

PerspectiveTools and standards

Amalie Høgh Eichler (University of Copenhagen) and colleagues published a new paper on PQS stability in phage lysates, showing PQS is highly stable in phage lysates for up to a year and can induce quorum sensing responses when carried over, potentially confounding phage-host interaction studies.

Research paperPhage-host interactionsQuorum sensing

The Online Citizen wrote a piece on Singapore General Hospital’s successful use of phage therapy to treat a patient using phages, which allowed the patient to avoid high-risk surgery.

NewsPhage therapyCompassionate use

Latest Jobs

Senior scientistPhage in foodFermentation
DSM-Firmenich is hiring a Sr. Scientist Strain Development Cultures ISOL, to study phage robustness of cheese starter cultures and lead phage research in Wageningen, Netherlands.
Senior scientistMicrobiome
Eligo Bioscience in Paris is hiring a Senior In-Vivo Scientist, to study host-microbiome interactions using in vivo, ex vivo, and in vitro models for preclinical development of microbiome therapeutics.

Community Board

Anyone can post a message to the phage community — and it could be anything from collaboration requests, post-doc searches, sequencing help — just ask!

Phagos and Amazon Web Services (AWS) are hosting a hackathon called Phagos x AWS — Hackdays 2025, taking place on May 14-15th, 2025. The event aims to leverage AI and LLMs for phage genome analysis, addressing antibiotic resistance and infectious diseases in animal farming. Participants can join on-site in Paris or remotely.

HackathonPhage and AIBioinformatics

I’m a chronic prostatitis patient who has tried Georgian & Russian phages before. While they did help, there was no lasting effect. I studied microbiology and so have faith in phages. I’d be looking for a place that could treat me, including by intra-prostatic injections/other delivery methods.

Main culprits: E. faecalis and K. pneumoniae, both pretty resistant but still susceptible to some antibiotics - all but gentamicin have been tried, including rare or last resort antibiotics and combinations, such as linezolid or thiamphenicol, etc.

https://chronicprostatitis.blogspot.com/p/feedback.html

Seeking phage therapy

Our Phage Picks for April 2025

Profile Image
Phage microbiologist and co-founder of Phage Directory
Co-founderStaff Scientist
Phage Directory, Stanford University, Stanford, United States
Skills

Phage-host interactions, Phage Therapy, Phage manufacturing, Phage delivery

I’m a co-founder of Phage Directory and have a PhD in Microbiology from the University of Alberta (I studied Campylobacter phage biology). For Phage Directory, I help physicians find phages for their patients, and I’m always trying to find new ways to help the phage field grow (especially through connecting people and highlighting awesome stuff I see happening in the field).

I spent 2022-2024 as a postdoc in Jon Iredell’s group at Westmead Institute for Medical Research in Sydney, Australia, helping get Phage Australia off the ground. I helped set up workflows for phage sourcing, biobanking, diagnostics, production, purification and QC of therapeutic phage batches, and helped build data collection systems to track everything we did. We treated more than a dozen patients in our first year, and I’m so proud of that!

As of 2024, I joined the Bollyky lab at Stanford University as a Staff Scientist, where I’m focused on phage engineering and delivery (to both microbial and human cells) and hydrogel-embedded phage cocktail development for wounds!

Profile Image
Product designer and co-founder of Phage Directory
Co-founderProduct Designer
Twitter @yawnxyz
Skills

Bioinformatics, Data Science, UX Design, Full-stack Engineering

I am a co-founder of Phage Directory, and have a Master of Human-Computer Interaction degree from Carnegie Mellon University and a computer science and psychology background from UMBC.

For Phage Directory, I design and build tools, and help write and organize Capsid & Tail.

I’ve previously worked at the Westmead Institute, for the Iredell lab at Phage Australia. There, I helped connect bioinformatics outputs and databases like REDCap, Google Drive, and S3-compatible storage systems.

Currently, I’m building and designing AI-centric tools for biology, including experimenting with protein models, biobank databases, AI-supported schema and data parsing, and bioinformatics workflows. Hit me up at [email protected] if you’re curious to collaborate!

Hello everyone!

It’s Phage Picks time! The theme of this week is ‘bread and butter’ — what are some bread and butter techniques for your phage lab, that you can rapidly adopt to dial in your quality/ease of work? The two papers I’m picking today surround solid yet simple methods for two major foundational things you will likely do repeatedly in a phage lab — producing/purifying phages, and quantifying/quality checking them.

One is my favourite methods paper of all time — Phage on Tap. I had to double check I hadn’t already chosen it as a Phage Pick! This paper is my favourite go-to paper for purifying any given phage. It’s lab-scale (small cultures), but high-purity (high enough to go into patients if you needed it to). The octanol method for removing endotoxin is still one of my favourite methods — reliable and extremely low-cost (you don’t need special equipment).

The other paper is one I haven’t personally tried, but I find myself telling people about all the time (and constantly telling myself to do this for all my favourite phages). Essentially it covers qPCR of phages, relating that to plaque assays, and monitoring that ratio for each phage as a way to have a holistic view of its quality/freshness/health. I think all phage labs should ultimately be striving to have PCR primers for their main phages, be checking titres this way (as well as through plaque assays), and using this combo of methods as a periodic quality/integrity check for their phages. If qPCR shows higher phage numbers than plaque assays, maybe you’ve got a degrading/less-than-fresh sample. If they’re staying constant, maybe you’ve got a happy, extra-stable phage! I’m not saying I currently do this, but I aspire to, and this paper is never far from my brain.

Also, beyond qPCR, even regular PCR would be a fabulous addition to routine phage quality checking, and I think we forget that this is so readily available to us. Instead of resequencing phages when we suspect that genetic drift is happening, or that a contaminant has been introduced, or when we’re not sure if two plaque morphologies in the same sample are two different phages or not, we could just be doing a PCR test to verify we get the band we should get for that phage. It’s not everything, but it’s something, and once you have the primers, it can be something you routinely check each time you make a new batch of phage.

Anyway, I hope you enjoy these two papers, and/or file them away in PDF form for a rainy day! Also, if there’s a methods paper you like, where you can say ‘I’ve used this and it works’, please email me! I’d love to feature more papers like this. A methods paper that truly works is gold — we should tell each other about them! (And write to the authors and tell them too — getting an email like that from a fellow scientist who actually read and used your paper is also gold).

Lastly, at the end of this issue, we’ve also got a bonus pick from Jan — what is optogenetics, and why hasn’t it changed the world yet?

Phage on tap–a quick and efficient protocol for the preparation of bacteriophage laboratory stocks

What is it about?

This paper describes a method called “Phage on Tap” (PoT) for quickly and efficiently preparing high-titer, homogeneous phage stocks for laboratory use. The method involves phage propagation, purification by filtration and chloroform treatment, concentration by ultrafiltration, removal of endotoxin using octanol, and storage in banks at 4°C. It can produce clean, high-titer phage stocks (up to 10^10-10^11 PFU/mL) within just 2 days, with limited equipment (just standard things most microbiology labs have) compared to 5+ days for traditional methods.

Why I’m excited about it:

  1. The PoT method is straightforward, fast, and efficient, allowing researchers to generate high-titre, homogeneous phage stocks quickly, without the need for specialized equipment.
  2. It includes steps for endotoxin removal, which is important for using phages in eukaryotic systems (from cell culture and immunology experiments to human patients).
  3. The method is extremely well-laid out/described, and it works almost every time I’ve used it, across many phages!

Overall, this protocol addresses key challenges in preparing phage stocks for research, is very well adapted to researchers in academia, and extremely clearly communicated. It could/should become a standard, default method (at least to start with) for phage biologists.

Source: Bonilla, N., Rojas, M. I., Cruz, G. N. F., Hung, S. H., Rohwer, F., & Barr, J. J. (2016). Phage on tap–a quick and efficient protocol for the preparation of bacteriophage laboratory stocks. PeerJ4, e2261. DOI: 10.7717/peerj.2261

Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)

What is it about?

This study developed a method using quantitative PCR (qPCR) to quickly and accurately count the number of phages in a cocktail of 5 different phages called BFC2. For each phage, they compared qPCR counts to the counts they got using plaque assays, the phage field’s gold standard for phage counting.

Key findings:

  • The qPCR method could accurately detect and count all 5 phages in the BFC2 mixture
  • qPCR was faster (3 hours vs 2 days) and less work than plaque assays
  • As expected, qPCR gave higher phage counts than plaque assays (since it detects all phage DNA, not just active phages)
  • The ratio between qPCR and culture counts was consistent for each phage type (!)
  • qPCR was more reproducible between different operators than the culture method

Why I’m excited about it:

This paper takes phage quantification from 1-dimensional to 2-dimensional. Using qPCR for phage quantification is not a novel concept in itself, but they describe doing this systematically for a set of phages, and specifically looking at the ratio for the two across the phages.

Being able to quickly determine phage concentrations is important for quality control in making therapeutic phage preps, quality control during phage research projects in general, and for monitoring phage levels during phage therapy. And bringing in a second method (and specifically looking at the relationship between the two methods) gives a fuller picture of not only phage quantity, but phage quality.

Also, the fact that the ratio looks to be phage-specific was really cool to me — this suggests you can use this as a fingerprint/a rapid check to confirm the identity/freshness/stability of your phage. Ratio off? Maybe the phage isn’t behaving like it should — maybe it’s not a fresh batch. Or maybe a contaminant was introduced?

While the plaque assay method is still needed to check if phages can infect bacteria strains (and is the only readily accessible, reliable method for counting the ACTIVE phages in your solution — at least under the conditions you’re testing), qPCR offers big advantages for rapid quantification of phage stocks. It makes a ton of sense as a complement to plaque assays, and should be used routinely to monitor stocks.

P.S. When I was at Phage Australia, I wrote a couple of blog posts on phage qPCR to monitor phage levels during phage therapy: part I and part II.

Source: Duyvejonck, H., Merabishvili, M., Pirnay, JP. et al. Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2). Sci Rep 9, 13893 (2019). https://doi.org/10.1038/s41598-019-50461-0

— Jess

Bonus: Optogenetics could change the world. So why hasn’t it?

This essay from a Stanford undergraduate student covers optogenetics, what it promised for many years, and why it never took off as everyone hoped it would. Optogenetics is basically a way to use light to control bacteria, similar to how our human eyes respond to light with photoreceptors, converting light into chemical signals.

Optogenetics has been a promising avenue for years (for example in neuroscience and medical treatments), but because of continued difficulties in gene therapy (and delivering light to specific body areas), it’s never reached its promise.

This article covers the challenges, road blocks, and explores whether it’s even worth exploring. It’s an inspiring Sunday afternoon read!

Article: https://www.owlposting.com/p/optogenetics-could-change-the-world

— Jan

Capsid & Tail

Follow Capsid & Tail, the periodical that reports the latest news from the phage therapy and research community.

We send Phage Alerts to the community when doctors require phages to treat their patient’s infections. If you need phages, please email us.

Sign up for Phage Alerts

In collaboration with

Mary Ann Liebert PHAGE

Supported by

Leona M. and Harry B. Helmsley Charitable Trust

Crossref Member Badge